Description
Steglatro is used with diet and exercise to help control blood sugar levels in adults with type 2 diabetes. Steglatro is classified as a sodium glucose co-transporter 2 (SGLT2) inhibitor.
The generic name for Steglatro is Ertugliflozin.
Fact Table |
Formula |
C22H25ClO7 |
License |
US DailyMed |
Bioavailability |
~100% |
Legal status |
Rx-only |
Chemical Name |
Ertugliflozin |
Elimination half-life |
~17 hours |
Dosage (Strength) |
5mg, 15mg |
Pregnancy |
Consult Doctor |
Brands |
Steglatro |
Protein binding |
93.6% |
PubChem CID |
44814423 |
MedlinePlus |
- |
ChEBI |
- |
ATC code |
A10BK04 |
DrugBank |
DB11827 |
KEGG |
D10313 |
Routes of administration |
By mouth |
Directions
Steglatro is supplied as either 5 mg or 15 mg tablets. The dosage ranges from 5 mg to 15 mg by mouth once daily in the morning with or without food.
It's important to evaluate the health of your kidneys before starting Steglatro use.
Ingredients
The active ingredient in Steglatro is Ertugliflozin.
Contraindications
You should discuss your allergies with your doctor. Do not take Steglatro if you are allergic to ertugliflozin or any of the other ingredients in Steglatro.
Do not take Steglatro if you are on dialysis.
Cautions
Once you are prescribed and buy Steglatro, know that there are certain medications that may interact with Steglatro. Before you start taking Steglatro, tell your doctor about any vitamins, herbal supplements, prescription, and over-the-counter medications you take.
- Stop taking Steglatro and call your doctor if you experience symptoms of ketoacidosis, including abdominal pain, nausea, vomiting, fatigue, and breathing problems.
- Stelagtro may increase your risk for leg or foot amputation. Immediately call your doctor if you experience new pain, tenderness, sores, infections, or ulcers in your lower limbs. Your doctor may then stop your Stelagtro.
- Before starting Steglatro, your kidney function should be evaluated and volume status corrected. Immediately tell your doctor if you are unable to eat or drink regularly or if you have nausea, vomiting, diarrhea, or have been in the heat too long because you could be dehydrated. Dehydration can cause kidney damage.
- If you are taking Steglatro with other medications that can lower your blood sugar, your blood sugar levels can drop. Use caution and monitor for symptoms of low blood sugar such as hunger, headache, irritability, shakiness, sweating, confusion, weakness, or a fast heartbeat. You should treat your low blood sugar as your doctor has instructed.
- You should seek medical care right away if you develop a fever or feel fatigued, weak, and have pain, swelling, or redness around your anus and genitals. These could be signs of a rare but serious bacterial infection that can damage the tissues beneath the skin near your anus and genitals.
- Consult your doctor if you have odor or white to yellowish discharge coming from your vagina or if you have vaginal itching. These could be signs that you have a vaginal yeast infection.
- Consult your doctor if you have pain, redness, itching, or swelling of your penis or if you have an odorous discharge that is coming from your penis. These could be signs that you have a penile yeast infection.
- Tell your doctor if you experience changes in urination, have pain or burning when urinating or if your urine is cloudy, light-pink, or red as these can be signs that you have a urinary tract infection.
- Tell your doctor if you are pregnant or plan to become pregnant. Because there is potential risk to the fetus, you should avoid taking Steglatro during the second and third trimesters of pregnancy.
- Tell your doctor if you are breastfeeding or plan to breastfeed. You should avoid taking Steglatro if you are breastfeeding.
Side Effects
If you experience any adverse effects while taking Steglatro, be sure to tell your doctor. Common side effects include:
- Changes in urination
- Vaginal yeast infection
- Penile yeast infection
References:
- STEGLATRO Prescribing Information. Whitehouse Station, NJ: Merk Sharp & Dhome Corp., 2021.
- Steglatro (ertugliflozin). Accessed November 9, 2021.
- Urinary tract infection (UTI). Mayo Clinic. Accessed November 16, 2021.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13235